Cardinal Health Board of Directors Approves Quarterly Dividend
Get Alerts CAH Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.9%
EPS Growth %: +15.7%
Join SI Premium – FREE
About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; and a provider of performance and data solutions. Our company's customer-centric focus drives continuous improvement and leads to innovative solutions that improve people's lives every day. Learn more about Cardinal Health at cardinalhealth.com and in our Newsroom.
Contacts
Media: Erich Timmerman, [email protected] and 614.757.8231
Investors:
View original content to download multimedia:https://www.prnewswire.com/news-releases/cardinal-health-board-of-directors-approves-quarterly-dividend-302686950.html
SOURCE Cardinal Health
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer
- Come Back to Firefox: Mozilla launches its most ambitious campaign yet to bring people back to the independent alternative to big tech browsers
- Best Crypto Presale 2026: JPMorgan Adds Two Funds to Solana as Remittix Recruits 100 Earn Testers
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share